This paper analyses the inter-firm R&D network formed in the pharmaceutical biotechnology industry during the 1990s from different perspectives: theoretical network formation, firm's structural positions and its collaborations at the entire network level, and the determinants for firm's...

This report is an account of the relationship between the ERA development and German research and innovation policy (R&I policy). The report introduces what ERA is and how the activities and instruments at European level have fundamentally changed and broadened. It provides a discussion of key...